Benet L, Sodhi J
Front Pharmacol. 2024; 15:1456677.
PMID: 39564109
PMC: 11574206.
DOI: 10.3389/fphar.2024.1456677.
Benet L, Sodhi J
Drug Metab Dispos. 2024; 52(9):932-938.
PMID: 38942444
PMC: 11331591.
DOI: 10.1124/dmd.124.001735.
Benet L, Sodhi J
Eur J Pharm Sci. 2024; 196:106753.
PMID: 38522769
PMC: 11813737.
DOI: 10.1016/j.ejps.2024.106753.
Bansal S, Ladumor M, Paine M, Unadkat J
Drug Metab Dispos. 2023; 51(6):743-752.
PMID: 36972999
PMC: 10197200.
DOI: 10.1124/dmd.122.001128.
Benet L, Sodhi J
Clin Pharmacol Ther. 2021; 111(5):1022-1035.
PMID: 34731496
PMC: 9542026.
DOI: 10.1002/cpt.2482.
Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized livers.
Yoshida K, Doi Y, Iwazaki N, Yasuhara H, Ikenaga Y, Shimizu H
Clin Transl Sci. 2021; 15(1):79-91.
PMID: 34080287
PMC: 8742647.
DOI: 10.1111/cts.13070.
Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?.
Sodhi J, Wang H, Benet L
Drug Metab Dispos. 2020; 48(7):537-543.
PMID: 32305951
PMC: 7289046.
DOI: 10.1124/dmd.120.090530.
Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method.
Calvier E, Krekels E, Johnson T, Rostami-Hodjegan A, Tibboel D, Knibbe C
AAPS J. 2019; 21(3):38.
PMID: 30850923
PMC: 6505506.
DOI: 10.1208/s12248-019-0295-0.
Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
Nishimuta H, Watanabe T, Bando K
AAPS J. 2019; 21(2):20.
PMID: 30673906
DOI: 10.1208/s12248-019-0294-1.
Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory.
Calvier E, Nguyen T, Johnson T, Rostami-Hodjegan A, Tibboel D, Krekels E
Pharm Res. 2018; 35(11):209.
PMID: 30218393
PMC: 6156772.
DOI: 10.1007/s11095-018-2487-1.
Reassessing models of hepatic extraction.
Ridgway D, Tuszynski J, Tam Y
J Biol Phys. 2013; 29(1):1-21.
PMID: 23345816
PMC: 3456842.
DOI: 10.1023/A:1022531403741.
Drug structure-transport relationships.
Roberts M
J Pharmacokinet Pharmacodyn. 2010; 37(6):541-73.
PMID: 21107662
PMC: 3005109.
DOI: 10.1007/s10928-010-9174-0.
Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research.
Tabata K, Hamakawa N, Sanoh S, Terashita S, Teramura T
Eur J Drug Metab Pharmacokinet. 2009; 34(2):117-28.
PMID: 19645221
DOI: 10.1007/BF03191160.
Prediction of human bioavailability from human oral administration data and animal pharmacokinetic data without data from intravenous administration of drugs in humans.
Imawaka H, Ito K, Kitamura Y, Sugiyama K, Sugiyama Y
Pharm Res. 2009; 26(8):1881-9.
PMID: 19418207
DOI: 10.1007/s11095-009-9902-6.
Prediction of hepatic clearance in human from in vitro data for successful drug development.
Chiba M, Ishii Y, Sugiyama Y
AAPS J. 2009; 11(2):262-76.
PMID: 19408130
PMC: 2691463.
DOI: 10.1208/s12248-009-9103-6.
Modeling kinetics of subcellular disposition of chemicals.
Balaz S
Chem Rev. 2009; 109(5):1793-899.
PMID: 19265398
PMC: 2682929.
DOI: 10.1021/cr030440j.
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
Uchaipichat V, Winner L, Mackenzie P, Elliot D, Williams J, Miners J
Br J Clin Pharmacol. 2006; 61(4):427-39.
PMID: 16542204
PMC: 1885031.
DOI: 10.1111/j.1365-2125.2006.02588.x.
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
Le Couteur D, Fraser R, Hilmer S, Rivory L, McLean A
Clin Pharmacokinet. 2005; 44(2):187-200.
PMID: 15656697
DOI: 10.2165/00003088-200544020-00004.
Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.
Ito K, Houston J
Pharm Res. 2004; 21(5):785-92.
PMID: 15180335
DOI: 10.1023/b:pham.0000026429.12114.7d.
In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.
Boase S, Miners J
Br J Clin Pharmacol. 2002; 54(5):493-503.
PMID: 12445028
PMC: 1874472.
DOI: 10.1046/j.1365-2125.2002.01669.x.